Over the last few years, businesses have begun to realize the importance of data and understand how it can change the way companies work. If we consider the growing demand for data in the U.S., and indeed the world, Palantir (NYSE: PLTR) looks like a great long-term investment for investors wanting a slice of the highly profitable big data analytics pie.
While Palantir does have competitors in its industry, the company remains a formidable force in its sector, evidenced by it winning government client after government client.
Palantir stock has been on a bit of a rollercoaster lately. Up over 12% over the last month, the stock has still gained almost 169% since its market debut last September.
Palantir is making a name for itself in the software industry by signing some top-class deals with Silicon Valley's finest, including recent contracts with IBM and Amazon's (NASDAQ: AMZN) AWS. In early Junel last year, Palantir also announced that it was expanding its work with Japanese-based Fujitsu with a one-year, $8 million contract between the two. Fujitsu will become the first distributor of Palantir's Foundry platform modules in Japan.
However, these contracts make up only a small portion of the market share potential, meaning there is still plenty of room for growth for Palantir.
The Denver-based company's fast growth was also proven in its most recent earnings report.
In 2021, Palantir's total revenue grew 41% to $1.54 billion year-over-year (YoY). What's more:
Palantir is known as one of the top providers of data analytics in the industry to some big government agencies. It has remained loyal to the U.S. government and this has helped it win multiple deals. For Q2, Palantir stated that revenue from the U.S. government had grown 90% YoY.
Over the past few months, Palantir has signed the following government contracts including:
Experts estimate that demand from government agencies is only going to increase in the coming years, which is great news for Palantir. The technology company is already helping the U.K. government with the Brexit border, working with its public healthcare sector, the NHS. During the pandemic, Palantir was also contracted by the U.S. Department of Health and the British National Health Service to help control the flow of coronavirus-related data.
Many have criticized Palantir for going after government contracts, but smart investors also realize that these types of clients give the company stable income that they can rely on.
With a market cap over $48 billion, the stock may look a little overvalued at the moment considering that Palantir is yet to report a profit. However, many shareholders believe that it's Palantir's massive growth opportunities, discussed above, that justify the company's high valuation.
Given the company's growing dominance in both the commercial and government sectors, the stock is becoming more of a solid investment for long-term investors.
The Home of Successful Investing.
© 2024 MyWallSt Ltd. All rights reserved.
Services
Social
Company
Support
This website is operated by MyWallSt Ltd (“MyWallSt”). MyWallSt is a publisher and a technology platform, not a registered broker-dealer or registered investment adviser, and does not provide investment advice. All information provided by MyWallSt Limited is of a general nature for information and education purposes, and you should not construe any such information as investment advice. MyWallSt Limited does not take your specific needs, investment objectives or financial situation into consideration, and any investments mentioned may not be suitable for you. You should always carry out your own independent verification of facts and data before making any investment decisions, as we cannot guarantee the accuracy or completeness of any information we publish and any opinions that we publish may be wrong and may change at any time without notice. If you are unsure of any investment decision you should seek a professional financial advisor. MyWallSt Limited is not a registered investment adviser and we do not provide regulated investment advice or recommendations. MyWallSt Limited is not regulated by the Central Bank of Ireland. MyWallSt Limited may provide hyperlinks to web sites operated by third parties. Your use of third party web sites and content, including without limitation, your use of any information, data, advertising, products, or other materials on or available through such web sites, is at your own risk and is subject to the third parties' terms of use.